We cloned a novel inhibitor of apoptosis protein (IAP) family member, BmIAP, from Bombyx mori BmN cells. BmIAP contains two baculoviral IAP repeat (BIR) domains followed by a RING domain. BmIAP shares striking amino acid sequence similarity with lepidopteran IAPs, SfIAP and TnIAP, and with two baculoviral IAPs, CpIAP and OpIAP, suggesting evolutionary conservation. BmIAP blocks programmed cell death (apoptosis) in Spodoptera frugiperda Sf-21 cells induced by p35 deficient Autographa californica nucleopolyhedrovirus (AcMNPV). This anti-apoptotic function requires both the BIR domains and RING domain of BmIAP. In mammalian cells, BmIAP inhibits Bax induced but not Fas induced apoptosis. Further biochemical data suggest that BmIAP is a specific inhibitor of mammalian caspase-9, an initiator caspase in the mitochondria/cytochrome-c pathway, but not the downstream effector proteases, caspase-3 and caspase-7. These results suggest that suppression of apoptosis by lepidopteran IAPs in insect cells may involve inhibition of an upstream initiator caspase in the conserved mitochondria/cytochrome-c pathway for apoptosis. ß
Introduction
Apoptosis or programmed cell death is a cellular suicide process in which damaged or harmful cells are eliminated from multicellular organisms [1] . Cells undergoing apoptosis have distinct morphological changes including cell shrinkage, membrane blebbing, chromatin condensation, apoptotic body formation and fragmentation [1] . This cell suicide program is evolutionarily conserved across animal species [2] . Apoptosis plays an important role in the development and homeostasis of metazoans [3] and is also critical in insect embryonic development and metamorphosis [4, 5] . Furthermore, apoptosis acts as a host defense mechanism by which virally infected cells are eliminated to limit the propagation of viruses [6] . Dysregulation of apoptosis has been associated with a variety of human diseases including cancer, neurodegenerative disorders and autoimmune diseases [7] .
Inhibitor of apoptosis proteins (IAPs) were originally discovered in baculoviruses [8, 9] . CpIAP and OpIAP are able to block apoptosis induced by p35 de¢cient baculovirus AcMNPV in insect Sf-21 cells [8, 9] . Cellular IAP homologues have been found in various animal species including worms, insects and humans [10, 11] . IAP proteins have distinctive primary structure. They contain one to three copies of baculoviral IAP repeat' (BIR) domain and most IAPs also contain a RING domain near their C-termini. The BIR domain contains a highly conserved arrangement of Cys/His residues forming a stable fold that chelates zinc [12, 13] . The BIR region was also found to interact with regulators of IAPs including Grim, Reaper and Hid from Drosophila and may also mediate homo-oligomerization [14^20]. The RING ¢nger is a common zinc binding motif that also exists in other cellular proteins [21] . Recent studies show that several IAPs, including XIAP, cIAP1, cIAP2, DIAP1, SfIAP and CpIAP, are inhibitors of caspases, a family of intracellular proteases responsible for the execution of the apoptosis program [222 8] . These IAPs can directly bind and inhibit some members of caspase family including caspase-3, -7 and -9. Structure^function studies have demonstrated that inhibition of caspase-3 and -7 requires only a single BIR domain while the RING domain may perform other functions including recruitment of ubiquitin conjugating enzymes [29] . When expressed without the associated BIRs, the RING region of SfIAP was found to enhance the proapoptotic activity of mammalian caspase-9 suggesting this domain operates as a trans-dominant inhibitor of endogenous proteins involved in apoptosis suppression [28] . Ectopic expression of lepidopteran SfIAP and baculoviral CpIAP blocks apoptosis in mammalian cells, suggesting conservation of the apoptosis program among various species and a shared mechanism used by the IAP family [28] . Bombyx mori (silkworm) has been domesticated for silk production for thousands of years. It has also been developed as an organism for large scale production of foreign proteins in the biotechnology industry [30] . Despite its extensive use in sericulture and biotechnology, no apoptosis regulating genes of silkworm have been identi¢ed so far. Here we report the cDNA cloning and characterization of a cellular IAP from a cell line (BmN) derived from B. mori and demonstrate that BmIAP is a direct inhibitor of mammalian caspase-9.
Materials and methods

Cloning of BmIAP
mRNA was isolated from BmN cells by using a kit from Qiagen. Degenerate primers were designed according to the consensus amino acid sequences between baculoviral IAPs and Drosophila IAPs:
Reverse transcription-polymerase chain reaction (PCR) was performed for 35 cycles by using 94³C for 45 s, 46³C for 1 min and 72³C for 1 min. Ampli¢ed fragments were blunt-end cloned into the HincII site of pTZ-19 and then sequenced. To obtain full length BmIAP cDNAs, 5P rapid ampli¢cation of cDNA ends (RACE) and 3P RACE were performed by using commercial kits (Gibco BRL; Takara) and 5P-CTGTTCCCACGGAACGTC-3P and 5P-GCCA-CCAATGATTCGAC-3P as internal PCR primers.
Plasmid construction
A cDNA fragment encompassing the complete open reading frame (ORF) of BmIAP was PCR ampli¢ed and subcloned into the EcoRI^XhoI sites in pcDNA3-myc and pGEX4T-1. Plasmids encoding fragments of BmIAP, including BIR1+2 (amino acid residue 1^292) and RING (residue 293^346), were ampli¢ed by PCR by using primers containing either start or stop codons as appropriate and subcloned into pTZ-19 and pcDNA3-myc plasmids.
Protein expression and puri¢cation
pGEX4T-1-BmIAP plasmid was introduced into Escherichia coli strain BL21 (DE3) containing the plasmid pT-Trx. Glutathione S-transferase (GST) fusion proteins were obtained by induction with 0.05 mM isopropyl L-thiogalactoside at 25³C for 8 h and then puri¢ed using glutathione-Sepharose [28] . The catalytic domains of caspase-3, caspase-7 and caspase-9 were expressed, puri¢ed by Ni-chelation a¤n-ity chromatography, and quanti¢ed as described [313 3].
Cell extracts and caspase assays
Cytosolic extracts were prepared by using human embryonic kidney (HEK) 293 cells [22] . For initiating caspase activation, 1 WM horse heart cytochrome-c (Sigma) and 1 mM dATP was added to extracts [24] . Caspase activity was assayed by release of 7-amino-4-tri£uoromethyl-coumarin (AFC) from Ac-DEVD-AFC or Ac-LEHD-AFC (Calbiochem), using a spectro£uorimeter as described [31, 34] .
Cell culture, transfection and apoptosis assays
Insect Sf-21 cells were maintained at 27³C in Excell 401 medium (JRH Biosciences, Lenexa, KS, USA) supplemented with 2.5% fetal bovine serum (FBS). vP35del, AcMNPV containing a deletion in the p35 gene, was propagated in TN-386 cells [35] . Plasmids encoding full length or deletion mutants of BmIAP (1 Wg) were co-transfected with 1 Wg vP35del viral DNA into Sf-21 cells by using lipofectin from Gibco BRL. Occlusion body formation was observed under light microscopy 3 days post-transfection.
HEK293 cells were maintained in Dulbecco's modi¢ed Eagle's medium (Irvine Scienti¢c) supplemented with 10% FBS, 1 mM L-glutamine and antibiotics. 293 cells (10 6 ) were cotransfected by using Superfect (Qiagen) with 0.1 Wg of green £uorescence protein (GFP) marker plasmid pEGFP (CLON-TECH), 0.25 Wg of either pcDNA3-Bax or pcDNA3-Fas and 1.5 Wg of pcDNA3-myc-BmIAP. Both £oating and adherent cells were recovered 243 6 h post-transfection and pooled, and the percent- age of GFP-positive cells with nuclear apoptotic morphology was determined by staining with 0.1 Wg/ml 4P-6-diamidino-2-phenylindole (DAPI) (mean þ S.D.; n = 3) [36] .
Results
Cloning of BmIAP
The full length BmIAP cDNA (GenBank accession number AF281073) contains a continuous ORF encoding a protein of 346 amino acids (Fig. 1) . This ORF is initiated by an AUG within a favorable context for translation [37] and is preceded by upstream stop codons in all three reading frames. Similar to SfIAP, the predicted BmIAP protein contains two BIR domains followed by a RING domain near its C-terminus (Fig. 1A,B) . In the BIR domain of BmIAP, the conserved presence and spacing of cysteine and histidine residue (CX 2 CX 6 WX 9 HX 6 C) is also observed. Within BIR and RING regions, BmIAP shares 88% amino acid identity (92% similarity) with SfIAP, 90% identity (92% similarity) with TnIAP and 76% identity (81% similarity) with CpIAP (Fig. 1C^E) . Thus BmIAP shares high sequence similarity with the other two lepidopteran IAPs, SfIAP and TnIAP, suggesting evolutionary conservation.
Both BIR and RING domains of BmIAP are required to block apoptosis induced by p35 de¢cient AcMNPV
To test the anti-apoptotic activity of BmIAP in insect cells, we co-transfected AcMNPV p35 de¢cient viral DNA into Sf-21 cells with plasmids containing full length BmIAP or truncation mutants of BmIAP lacking two BIR domains or the RING domain. IAPs that have anti-apoptotic function in insect cells are able to rescue p35 de¢cient AcMNPV, allowing virus replication and resulting in occlusion body formation which serves as a visual screening end-point under light microscopy [8, 9] . Since SfIAP has been shown to block apoptosis in both insect and mammalian cells [28] , whereas AcIAP is ine¡ective [6, 28] , SfIAP and AcIAP were used as positive and negative controls, respectively (Fig. 2D,E) .
A plasmid encoding the full length BmIAP was able to complement the p35 de¢ciency in the baculovirus, supporting occlusion body production and virus replication at 3 days post-transfection ( Fig. 2A) . In contrast, neither the BIR nor RING domain deletion mutants of BmIAP were able to support occlusion body formation. Sf-21 cells displayed morphological changes of apoptosis such as apoptotic body formation when either the BIR or RING domain deletion mutants were co-transfected with p35 de¢cient viral DNA (Fig. 2B,C) . These results demonstrate that both the BIR and RING domain regions of BmIAP are required in combination for the anti-apoptotic function of BmNPV in insect cells.
BmIAP inhibits Bax induced but not Fas induced apoptosis in mammalian cells
SfIAP and baculoviral IAPs were previously shown to block apoptosis in mammalian cells [28,38^40] . To explore whether BmIAP has similar properties, we co-expressed BmIAP in HEK293 cells with either Fas or Bax, representing two major pathways that utilize caspase-8 and caspase-9, respectively, as their apical proteases. Similar to SfIAP, full length BmIAP inhibited Bax (Fig. 3A) but not Fas induced apoptosis (Fig. 3B) . In contrast human XIAP protected cells against both Bax and Fas induced apoptosis. As in Sf-21 cells, the inhibition of Bax induced apoptosis in mammalian cells also requires both the BIR and RING domains of BmIAP suggesting the conservation of the structural requirements for inhibition (Fig. 3A) . Immunoblot analysis indicated that the levels of the BIR and RING truncation proteins were similar to that of full length BmIAP in transfected cells, excluding di¡erences in protein levels as an explanation for the failure of the BIR domains or RING domain to suppress cell death (data not shown).
These results were further con¢rmed in a cell-free system in which exogenously added cytochrome-c, an agonist of the caspase-9 activating protein Apaf-1 [41] , induces activation of caspase-3 and similar effector proteases, as measured by hydrolysis of Ac-DEVD-AFC [34] . In cytosolic extracts treated with cytochrome-c, recombinant BmIAP and positive control recombinant SfIAP completely blocked the hydrolysis of Ac-DEVD-AFC whereas negative control recombinant XIAP-BIR1 had no e¡ect on caspase activity (Fig. 3C ). Since caspase-3 and -7 are common to both Bax and Fas pathways, these results suggest BmIAP, like SfIAP, inhibits the mitochondria/cytochrome-c pathway in mammalian cells, thus, suppressing apoptosis at a step upstream of caspase-3 and -7. This point is supported by the ob- (C) Recombinant BmIAP (2 WM) was added to cytosolic extracts (10 mg/ml) from HEK293 cells concurrently with the addition of 1 WM cytochrome-c/1 mM dATP. After incubation at 30³C for 10 min, aliquots were withdrawn and assayed for caspase activity as measured by release of AFC from Ac-DEVD-AFC substrate (100 WM). Data are presented as a percentage relative to control reaction in which cytochrome-c/dATP were added alone. Fig. 4 . BmIAP directly suppresses caspase-9 but not caspase-3 or caspase-7. Recombinant active (A) caspase-9 was added at 0.2 WM and incubated at 37³C with Ac-LEHD-AFC substrate (100 WM) in the presence or absence of various concentration (0.2^1.6 WM) of recombinant puri¢ed BmIAP or SfIAP. AFC release was measured continuously. Data are expressed as a percentage relative to control reactions lacking IAPs, using rates determined from the linear portion of enzyme progress curves. Various control GST-fusion proteins had no inhibition e¡ect (not shown). (B) Recombinant caspase-3 (2.6 nM) was incubated at 37³C with Ac-DEVD-AFC substrate (100 WM) in the presence or absence of 0.05 WM GST-XIAP, 0.5 WM GSTBmIAP (200-fold molar excess to caspase) or 0.5 WM GSTSfIAP (200-fold molar excess). AFC release was measured as above. (C) Recombinant caspase-7 (7.0 nM) was incubated at 37³C with Ac-DEVD-AFC substrate (100 WM) in the presence or absence of 0.14 WM GST-XIAP, 0.7 WM GST-BmIAP (100-fold molar excess relative to caspase) or 0.7 WM GST-SfIAP (100-fold molar excess). AFC release was measured as above.
servation that BmIAP does not inhibit caspase-3 and -7 in vitro (see Section 3.4).
BmIAP is a direct inhibitor of caspase-9
Since caspase-3, -7 and -9 are involved in the apoptotic pathway induced by Bax and since SfIAP has been shown to directly inhibit caspase-9 [28] , we examined the possibility that BmIAP is also a direct caspase-9 inhibitor. Puri¢ed recombinant BmIAP was incubated with puri¢ed recombinant caspase-9. Residual activity was measured using Ac-LEHD-AFC as a substrate of caspase-9. BmIAP inhibited recombinant caspase-9 in a concentration dependent manner. The relative amount of BmIAP required for caspase-9 inhibition was Veight-fold molar excess, similar to the results reported previous for SfIAP and XIAP (Fig. 4A) [26, 28] . Unlike XIAP, but similar to SfIAP, BmIAP did not inhibit recombinant caspase-3 and caspase-7, suggesting a narrower speci¢city compared to human XIAP (Fig. 4B,C) .
Discussion
Studies of lepidopteran SfIAP and baculoviral CpIAP demonstrate that they block apoptosis by inhibiting caspases [28] . In this report, we cloned a novel lepidopteran IAP, BmIAP, from B. mori and provide direct evidence that this lepidopteran IAP can also function as a caspase inhibitor. BmIAP shares strong amino acid sequence similarity with SfIAP, TnIAP and baculoviral CpIAP. Structuref unction analysis of BmIAP reveals identical domain requirements (e.g. BIR plus RING) for suppression of apoptosis in both insect and mammalian cells and similar caspase selectivity (e.g. caspase-9) compared to the previously characterized lepidopteran and baculovirus IAPs. These results strongly support the idea that lepidopteran IAPs are evolutionary conserved in both sequence and function.
Similar to SfIAP and CpIAP, ectopic expression of BmIAP blocks Bax induced but not Fas induced apoptosis in mammalian cells. This inhibitory e¡ect requires both the BIR and RING domains. Since caspase-3 and -7 operate at the point of convergence of the Bax and Fas pathways, these observations suggested that caspase-9 is the speci¢c target of BmIAP. Direct con¢rmation of inhibition of caspase-9 by BmIAP was obtained by in vitro studies, revealing that puri¢ed recombinant BmIAP directly inhibits mammalian caspase-9 in vitro. The interesting question remains what is the endogenous caspase target of BmIAP in silkworm. Baculoviral IAPs which share a high degree of amino acid sequence identity with BmIAP have been shown to prevent activation of Sf-procaspase-1, a putative counterpart of mammalian downstream caspases, but do not directly inhibit active Sf-caspase-1 [42] . We therefore speculate that the target of BmIAP is an upstream insect caspase which is analogous to caspase-9. The recently published genome from Drosophila melanogaster identi¢ed eight caspases [43] . Three of these caspases contain long prodomains and thus are likely to serve as candidates of upstream initiator caspases analogous to caspase-9 of mammals. A recent study also showed that DIAP1, a counterpart of BmIAP in £ies, directly binds and inhibits DRONC, one of the three putative upstream insect caspases [19] . Cloning and characterization of caspases from B. mori will shed new light on the speci¢c target of BmIAP and yield a better understanding of apoptotic pathways in B. mori.
Drosophila and mammalian IAPs have been shown to play important roles in the development of these organisms [44, 45] . By analogy, it seems reasonable to speculate that BmIAP is also a critical player in silkworm development. We therefore envision that manipulation of apoptosis during the development of the silkworm could have a positive impact on the sericulture and biotechnology industries in the future.
(Q.L.D). We dedicate this paper to Professor Susumu Maeda, who passed away during the completion of the project.
